Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/D000079982
http://purl.bioontology.org/ontology/MESH/D000079982
|
|---|---|
| Preferred Name | Gemtuzumab |
| Definitions |
Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA.
|
| Synonyms |
CMA676
CMA 676
CMA-676
Gemtuzumab-Ozogamicin
Mylotarg
Gemtuzumab Ozogamicin
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA. |
|---|---|
| altLabel |
CMA676
CMA 676
CMA-676
Gemtuzumab-Ozogamicin
Mylotarg
Gemtuzumab Ozogamicin
See more
See less
|
| prefLabel | Gemtuzumab
|
| Machine permutation | 2020; GEMTUZUMAB was indexed under AMINOGLYCOSIDES and ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2019; and under ANTIBODIES, MONOCLONAL 2000-2011
|
| HN | 2020 (2000)
|
| type | |
| isa | |
| PA |
D000074322
D000922
|
| tui |
T116
T129
T121
|
| TERMUI |
T000949341
T000949340
T431375
T000949339
T411115
T411114
See more
See less
|
| TH |
US
NLM (2009)
NLM (2000)
FDA SRS (2017)
NLM (2001)
USAN (19XX)
INN (19XX)
See more
See less
|
| MMR | 20200101
|
| notation | D000079982
|
| Semantic type UMLS property | |
| RR | 8GZG754X6M
|
| Inverse of AQ |
See more
See less
|
| DX | 20200101
|
| cui |
C0876099
C0677800
C1533699
C0872968
|
| DC | 1
|
| MN |
D12.776.124.486.485.114.224.060.790
D09.408.051.247.500
D12.776.377.715.548.114.224.200.790
D12.776.124.790.651.114.224.060.790
|
| LT | TRD
|
| AQL | AD AE AN BL CF CH CL DE EC GE HI IM IP ME PD PK PO RE TO TU UL UR
|
| Inverse of RB |
93NS566KF7
0
8GZG754X6M
|
| MDA | 20181206
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |